Intellia Therapeutics (NTLA) Equity Ratio (2015 - 2026)

Intellia Therapeutics (NTLA) reported Equity Ratio of 0.82 for Q1 2026, up 3.47% year-over-year from 0.79 in Q1 2025, and up 2.64% on a QoQ basis from 0.8 in Q4 2025.

Intellia Therapeutics (NTLA) has 12 years of Equity Ratio data on file, last reported at 0.82 in Q1 2026.

  • Quarterly Equity Ratio rose 3.47% year-over-year to 0.82 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.82 (up 3.47% YoY) and the FY2025 annual result came in at 0.8, up 8.9% from the prior year.
  • Equity Ratio climbed to 0.82 in Q1 2026 per NTLA's latest filing, from 0.8 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.84 in Q1 2023 and bottomed at 0.73 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.81 (2025), against an average of 0.8.
  • The widest annual swing landed in 2023, when Equity Ratio grew 9.68%; it then retreated 9.3% in 2024.
  • Tracing NTLA's Equity Ratio over 5 years: stood at 0.81 in 2022, then fell by 0.69% to 0.81 in 2023, then declined by 9.3% to 0.73 in 2024, then advanced by 8.9% to 0.8 in 2025, then increased by 2.64% to 0.82 in 2026.
  • Per Business Quant, the three latest NTLA Equity Ratio figures stand at 0.82 (Q1 2026), 0.8 (Q4 2025), and 0.81 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Intellia Therapeutics 1.63 Bn 1.63 Bn - 0.82

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.82
Dec 31, 2025 0.80
Sep 30, 2025 0.81
Jun 30, 2025 0.80
Mar 31, 2025 0.79
Dec 31, 2024 0.73
Sep 30, 2024 0.82
Jun 30, 2024 0.81
Mar 31, 2024 0.82
Dec 31, 2023 0.81
Sep 30, 2023 0.83
Jun 30, 2023 0.83
Mar 31, 2023 0.84
Dec 31, 2022 0.81
Sep 30, 2022 0.76
Jun 30, 2022 0.79
Mar 31, 2022 0.79
Dec 31, 2021 0.80
Sep 30, 2021 0.83
Jun 30, 2021 0.74
Mar 31, 2021 0.76
Dec 31, 2020 0.78
Sep 30, 2020 0.72
Jun 30, 2020 0.72
Mar 31, 2020 0.79
Dec 31, 2019 0.81
Sep 30, 2019 0.80
Jun 30, 2019 0.79
Mar 31, 2019 0.77
Dec 31, 2018 0.80
Sep 30, 2018 0.82
Jun 30, 2018 0.82
Mar 31, 2018 0.82
Dec 31, 2017 0.80
Sep 30, 2017 0.71
Jun 30, 2017 0.71
Mar 31, 2017 0.72
Dec 31, 2016 0.70
Sep 30, 2016 0.72
Jun 30, 2016 0.72
Mar 31, 2016 -0.36
Dec 31, 2015 -0.26